We are constantly focusing and investing in innovation activities. Our continuous efforts in R&D aim to develop innovative products and formulations for the needs of oncology patients. Our highly scientific team collaborates with research and clinical institutions, providing additional resources and expertise to complement its core competencies.
We are very proud to announce that we have received the research grant SEED/0719/0200 from the Republic of Cyprus through the Research & Innovation Foundation and the European Regional Development Fund. The project mediSKIN “Development of novel medical-grade skincare products for oncology patients” has a duration of two years (June 2021-May 2023) and a total budget of €498,505.